Dan Haugen

Dan Haugen is a Minneapolis-based freelance writer who covers growing companies and new technologies for several print and online publications.

Posts by Dan Haugen

presented by
News

Mayo Clinic announces $100 million gift for proton beam therapy program

The Mayo Clinic Proton Beam Therapy Program will use an advanced type of proton beam therapy known as pencil beam scanning, which uses a narrower beam. Developed at a Swiss physics institute about a decade ago, it's still only in use at a few centers. The MD Anderson Cancer Center at the University of Texas in Houston became the first U.S. clinic to begin using the treatment in 2008. Harvard's Massachusetts General Hospital announced the addition pencil-beam scanning at its center in 2009.

Devices & Diagnostics

CEO: Uroplasty’s Q3 performance ‘began to reflect potential’

Uroplasty‘s performance finally “began to reflect the potential of the company” in the third quarter, CEO David Kaysen said Thursday during the company’s earnings call. The Minnetonka, Minnesota, device company ramped up its sales force, won over five new regional Medicare carriers, and boosted global sales by 14 percent to $3.5 million during the quarter, […]

Devices & Diagnostics

New SurModics CEO looks to focus on a ‘secret sauce’ after Ramius drama

SurModics hosted its first earnings call since naming a new CEO in December and resolving a brief standoff with activist shareholder, Ramius LLC. The loss was expected, and the earnings call instead centered on the newly appointed CEO Gary Maharaj, who spoke about a need to identify and refocus on the company's efforts on a "well-defined core." What exactly that core is, however, is yet to be defined.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

Health IT

Mayo Clinic names 17 members to social media advisory board

Mayo Clinic's Center for Social Media named 17 members Wednesday to its advisory board, which will help draft industry guidelines and best practices for using social media to improve health care. Mayo launched the social media center last summer with the goal of helping the health care community improve care through the use of social media tools like Twitter, Facebook and YouTube.

Devices & Diagnostics

Urologix blames turnover, economy, reimbursement confusion for Q2 loss

The Plymouth-based company develops devices for treating enlarged prostate, or benign prostatic hyperplasia. Its Targis System uses microwave energy to heat and destroy enlarged prostate tissue as an alternative to pharmaceutical treatment. "The second quarter's results are disappointing and inconsistent with the efforts towards sustained, sequential revenue growth," CEO Stryker Warren Jr. said during the company's conference call.